Stoke Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.About STOK
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.
CEOIan Frederick Smith
CEOIan Frederick Smith
Employees128
Employees128
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2014
Founded2014
Employees128
Employees128
STOK Key Statistics
Market cap1.78B
Market cap1.78B
Price-Earnings ratio46.92
Price-Earnings ratio46.92
Dividend yield—
Dividend yield—
Average volume861.19K
Average volume861.19K
High today$31.54
High today$31.54
Low today$30.02
Low today$30.02
Open price$30.60
Open price$30.60
Volume660.41K
Volume660.41K
52 Week high$38.69
52 Week high$38.69
52 Week low$5.35
52 Week low$5.35
Stock Snapshot
With a market cap of 1.78B, Stoke Therapeutics(STOK) trades at $31.05. The stock has a price-to-earnings ratio of 46.92.
On 2025-12-04, Stoke Therapeutics(STOK) stock moved within a range of $30.02 to $31.54. With shares now at $31.05, the stock is trading +3.4% above its intraday low and -1.6% below the session's peak.
Trading volume for Stoke Therapeutics(STOK) stock has reached 660.41K, versus its average volume of 861.19K.
Over the past 52 weeks, Stoke Therapeutics(STOK) stock has traded between a high of $38.69 and a low of $5.35.
Over the past 52 weeks, Stoke Therapeutics(STOK) stock has traded between a high of $38.69 and a low of $5.35.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.